Xiaolong Li

784 total citations
48 papers, 492 citations indexed

About

Xiaolong Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaolong Li has authored 48 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xiaolong Li's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Venomous Animal Envenomation and Studies (4 papers). Xiaolong Li is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Venomous Animal Envenomation and Studies (4 papers). Xiaolong Li collaborates with scholars based in China, United States and Mexico. Xiaolong Li's co-authors include Qingfeng Ni, Jianwei Zhu, Wei‐Yi Chen, Guohua Lü, Hongli Li, Baogang Zhang, Chonggao Yin, Lei Sun, Yuqing Liu and Shijun Lu and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Xiaolong Li

44 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolong Li China 13 288 115 99 56 54 48 492
Yuexin Xu China 13 303 1.1× 97 0.8× 131 1.3× 75 1.3× 31 0.6× 31 556
Marie Bénéteau France 10 456 1.6× 183 1.6× 91 0.9× 112 2.0× 28 0.5× 11 659
Xiaoyan Gu China 14 373 1.3× 243 2.1× 49 0.5× 66 1.2× 38 0.7× 28 565
Yang Dong China 13 394 1.4× 162 1.4× 108 1.1× 67 1.2× 32 0.6× 32 584
Weiwei Du China 12 299 1.0× 89 0.8× 144 1.5× 115 2.1× 99 1.8× 16 580
Wendong Guo China 13 260 0.9× 66 0.6× 53 0.5× 54 1.0× 27 0.5× 26 460
Hyun‐Jung An South Korea 15 395 1.4× 115 1.0× 108 1.1× 169 3.0× 36 0.7× 22 627
Mei Yan China 11 317 1.1× 166 1.4× 49 0.5× 32 0.6× 33 0.6× 31 585
Jiin‐Tsuey Cheng Taiwan 14 249 0.9× 49 0.4× 53 0.5× 35 0.6× 44 0.8× 17 455
Cenk Kığ Türkiye 8 449 1.6× 136 1.2× 68 0.7× 46 0.8× 42 0.8× 16 649

Countries citing papers authored by Xiaolong Li

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Li more than expected).

Fields of papers citing papers by Xiaolong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Li. The network helps show where Xiaolong Li may publish in the future.

Co-authorship network of co-authors of Xiaolong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Li. A scholar is included among the top collaborators of Xiaolong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Li. Xiaolong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Peng, Bingjie Li, Xiaolong Li, et al.. (2025). Porcine epidemic diarrhea virus induces mitophagy to inhibit the apoptosis and activation of JAK/STAT1 pathway. Veterinary Microbiology. 303. 110427–110427. 2 indexed citations
2.
Cheng, Y., Jing Shi, Xiaolong Li, et al.. (2025). 302P: Phase II study of the efficacy and safety of BNT327/PM8002 plus systemic chemotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC). Journal of Thoracic Oncology. 20(3). S185–S185. 1 indexed citations
4.
Li, Xiaolong, Qingbo Liu, Bin Liang, et al.. (2025). Identification and validation of shared biomarkers and drug repurposing in psoriasis and Crohn’s disease: integrating bioinformatics, machine learning, and experimental approaches. Frontiers in Immunology. 16. 1587705–1587705. 1 indexed citations
5.
Li, Junfu, et al.. (2024). Deep learning method for online parameter identification of lithium-ion batteries using electrochemical synthetic data. Energy storage materials. 72. 103697–103697. 9 indexed citations
6.
Li, Hong, et al.. (2024). Effect of the Nucleosome-Depleted Region in the Transcribed Regions of Saccharomyces cerevisiae Genes on Exogenous Gene Expression. Applied Sciences. 14(23). 11339–11339. 1 indexed citations
7.
Fu, Xin, Yuxiang Liu, Xiaolong Li, et al.. (2024). Integrated Analysis of Metabolome and Transcriptome Reveals the Effect of Burdock Fructooligosaccharide on the Quality of Chinese Cabbage (Brassica rapa L. ssp. Pekinensis). International Journal of Molecular Sciences. 25(21). 11459–11459. 1 indexed citations
8.
Li, Xiaolong, et al.. (2024). Future focus: unlocking self-control and meaning in life to combat smartphone addiction. Current Psychology. 43(42). 33050–33058. 1 indexed citations
9.
Li, Ling, et al.. (2024). ADH4—a potential prognostic marker for hepatocellular carcinoma with possible immune-related implications. BMC Cancer. 24(1). 927–927. 2 indexed citations
10.
Yang, Ziping, Qi Liu, Xiaolong Li, et al.. (2023). A chromosome-level genome assembly of Agave hybrid NO.11648 provides insights into the CAM photosynthesis. Horticulture Research. 11(2). uhad269–uhad269. 6 indexed citations
11.
Liu, Yongqiang, Xiaolong Li, Qing Chen, et al.. (2021). Transcriptome Profile Analysis of Strawberry Leaves Reveals Flowering Regulation under Blue Light Treatment. International Journal of Genomics. 2021. 1–18. 18 indexed citations
12.
Zhang, Yan, Dong Tang, Xiaolong Li, et al.. (2021). Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway. Acta Biochimica et Biophysica Sinica. 53(11). 1547–1557. 8 indexed citations
13.
Li, Xiaolong, Emmanuel Martínez-Ledesma, Chen Zhang, et al.. (2019). Tie2–FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in Glioblastoma. Cancer Research. 79(19). 5088–5101. 20 indexed citations
14.
Yu, Guofeng, Xianmei Meng, Hong Hong, et al.. (2019). Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma. Molecular and Cellular Biochemistry. 460(1-2). 37–51. 7 indexed citations
15.
Yu, Jiawei, Qingfeng Ni, Xiaofei Zhi, et al.. (2019). Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway. Biomedicine & Pharmacotherapy. 121. 109630–109630. 45 indexed citations
16.
Xu, Weibin, Li Xu, Huayu Wu, et al.. (2017). Expression, purification and characterization of a novel recombinant SVTLE, r- agkihpin-2, from Gloydius halys Pallas venom gland in Escherichia coli. Protein Expression and Purification. 136. 7–13. 2 indexed citations
17.
Huang, Miao, Sheng‐Ming Wu, Qiping Hu, et al.. (2016). Agkihpin, a novel SVAE may inhibit the migration and invasion of liver cancer cells associated with the inversion of EMT induced by Wnt/β-catenin signaling inhibition. Biochemical and Biophysical Research Communications. 479(2). 283–289. 18 indexed citations
18.
19.
Liu, Yuqing, Xiaolong Li, Liu Fei, et al.. (2014). Gab2-Akt-ARK5 signaling pathway is associated with the invasion of glioma cells. Clinical Oncology and Cancer Research. 551–554. 1 indexed citations
20.
Yin, Chonggao, Hongli Li, Baogang Zhang, et al.. (2013). RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition. Breast Cancer Research and Treatment. 142(2). 297–309. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026